$1.89
+0.04 (+2.16%)
Performance
1D
—
1W
+14.55%
1M
+8.00%
3M
-25.30%
6M
-80.04%
1Y
-90.05%
YTD
-90.05%
Open$1.90
Previous Close$1.85
Day High$2.00
Day Low$1.72
52W High$24.09
52W Low$1.28
Volume—
Avg Volume619.0K
Market Cap1.03B
P/E Ratio—
EPS$-1.04
SectorN/A
Technical Indicators
Full analysis →
SMA 50
$2.49
Below
SMA 200
$5.89
Below
RSI (14)
65
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
9 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 897.79M | 924.30M | 800.01M |
| Net Income | 130.26M | 123.87M | 128.43M |
| Profit Margin | 14.5% | 13.4% | 16.1% |
| EBITDA | 262.26M | 279.12M | 215.46M |
| Free Cash Flow | 117.43M | 106.34M | 120.15M |
| Rev Growth | +21.7% | -6.1% | -8.9% |
| Debt/Equity | 0.23 | 0.23 | 0.24 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| PICS | Pics Nv | $7.10 | -9.67% | 3.7 | 920.07M |
| DMII | Drugs Made In America Acquis | $10.22 | -0.05% | 49.9 | 649.74M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.59 | +0.00% | 27.6 | 219.04M |
| CEPF | Cantor Equity Partners-Cl A | $10.32 | -0.10% | 41.5 | 589.79M |
| BCSS | Bain Capital Gss Inv- A | $10.22 | +0.05% | 48.7 | 597.72M |